With the year’s biggest annual dermatology conference just winding down here in Washington, DC, the announcements concerning new and emerging psoriasis treatments have been abundant and encouraging. Two more were recently released.
We note these not because they appear more (or less) promising than any of the others, but merely to note once again the interest in the biotech and pharmaceutical sectors in psoriasis research and treatments. We also like the fact that seemingly random collections of letters and numbers — JB991, AN2728 — might one day be the answer for someone’s psoriasis. (After all, many of the treatments helping people today started out as code numbers.)
There are presently more than SEVENTY potential treatments for psoriasis and psoriatic arthritis being studied. That is a stunning number.
Category: Uncategorized
